Table 3.
Subgroup analysis.
Outcomes | Dose | No. of studies | Heterogeneity | SMD(95%CI) | P Value | |
---|---|---|---|---|---|---|
I2 | P | |||||
C-reactive protein | < 500 mg | 2 | 99.2% | < 0.0001 | -4.88(-11.72, 1.96) | 0.162 |
≥ 500mg | 5 | 89.7% | < 0.0001 | -0.18(-0.88, 0.53) | 0.626 | |
Interleukin-6 | < 500 mg | 3 | 99% | < 0.0001 | -2.20(-5.12, 0.71) | 0.140 |
≥ 500mg | 2 | 0 | 0.7 | -0.19(-0.50, 0.12) | 0.220 |
SMD, Standard mean difference; CI, Confidence interval